A non-human primate study has demonstrated that a novel gene therapy could provide an effective approach for neuronal regeneration in brains damaged by ischemic stroke. Currently stroke treatment has a very narrow timeframe, requiring administration within a few hours of stroke onset, and therapies typically have the aim of restoring blood flow and protecting the intact brain tissue. In areas where access to hospitals is limited, many people are unable to receive the required treatment in time, suffering a large amount of neuronal death as a result. To overcome the time-sensitive nature of stroke treatment, multiple research groups have been...
To view this content, please register now for access
Become a member of BioTechniques for FREE to receive:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!